Clinical endpoint | Prognosticator | HR | 95% CI | P value |
---|---|---|---|---|
OS | ETAR expression | 1.93 | 1.11-3.38 | 0.02 |
UICC stage | 1.54 | 1.19-2.01 | 0.001 | |
N classification | 1.42 | 1.12-1.80 | 0.003 | |
Gender | 0.57 | 0.34-0.93 | 0.026 | |
 | Age | 1.98 | 1.28-3.07 | 0.002 |
PFS | ETAR expression | 2.58 | 1.28-5.22 | 0.008 |
UICC stage | 1.36 | 1.02-1.84 | 0.04 | |
N classification | 1.42 | 1.1-1.84 | 0.007 | |
 | Gender | 0.47 | 0.25-0.89 | 0.02 |
DMFS | ETAR expression | 4.62 | 1.66-12.86 | 0.003 |
 | N classification | 1.92 | 1.46-2.54 | <0.001 |
LRRFS | UICC stage | 1.76 | 1.22-2.54 | 0.002 |